Screening for congenital adrenal hyperplasia yields positive outcomes

06/3/2014 | MedWire News (U.K.)

A nationwide newborn screening program introduced in Sweden detected all salt-wasting congenital adrenal hyperplasia cases between 1986 and 2011, according to a study in the journal JAMA Pediatrics. The neonatal testing had a sensitivity rate of 84.3% for all forms of CAH and resulted in low recall rates for full-term and preterm babies.

View Full Article in:

MedWire News (U.K.)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
Actuary
Meridian Health Plan
Detroit, MI
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Director, Payer Marketing
Avalere Health
Washington, DC